TrialInternational urology and nephrology2024

Repurposing fexofenadine as a promising candidate for diabetic kidney disease: randomized clinical trial.

Basma Mahrous El-Fatatry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.